Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description
Brandi ML et al., her Adv Chronic Dis. 2022 Sep 5;13:20406223221117471
Post-authorisation safety study of burosumab use in paediatric, adolescent and adult patients with X-linked hypophosphataemia: rationale and description
Brandi ML et al., her Adv Chronic Dis. 2022 Sep 5;13:20406223221117471